Skip to content

Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate

C44H85NO5 — CID 168821455

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACheptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate
SMILESCCCCCCCCCOC(=O)CCCCCC1C(CCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCN1CCO
InChIInChI=1S/C44H85NO5/c1-4-7-10-13-16-19-28-39-49-43(47)33-26-21-25-32-42-40(35-36-45(42)37-38-46)29-22-20-27-34-44(48)50-41(30-23-17-14-11-8-5-2)31-24-18-15-12-9-6-3/h40-42,46H,4-39H2,1-3H3
InChIKeyQJJUYFJBFYIAOV-UHFFFAOYSA-N
MW708.17 g/mol
LogP12.28
Rot. Bonds37

About Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate

Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate (PubChem CID 168821455) has the molecular formula C44H85NO5 and a molecular weight of 708.17 g/mol. Its IUPAC name is heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate.

Molecular Properties

Compound NameHeptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate
PubChem CID168821455
Molecular FormulaC44H85NO5
Molecular Weight708.17 g/mol
Exact Mass707.64
IUPAC Nameheptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate
SMILESCCCCCCCCCOC(=O)CCCCCC1C(CCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCN1CCO
InChIInChI=1S/C44H85NO5/c1-4-7-10-13-16-19-28-39-49-43(47)33-26-21-25-32-42-40(35-36-45(42)37-38-46)29-22-20-27-34-44(48)50-41(30-23-17-14-11-8-5-2)31-24-18-15-12-9-6-3/h40-42,46H,4-39H2,1-3H3
InChIKeyQJJUYFJBFYIAOV-UHFFFAOYSA-N
XLogP12.28
TPSA76.07 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds37
Heavy Atoms50
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500708.17
LogP ≤ 512.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate?
The IUPAC name of Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate (CID 168821455) is heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate.
What is the SMILES notation for Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate?
The canonical SMILES for Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate is CCCCCCCCCOC(=O)CCCCCC1C(CCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCN1CCO.
What is the InChIKey of Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate?
The InChIKey is QJJUYFJBFYIAOV-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H85NO5/c1-4-7-10-13-16-19-28-39-49-43(47)33-26-21-25-32-42-40(35-36-45(42)37-38-46)29-22-20-27-34-44(48)50-41(30-23-17-14-11-8-5-2)31-24-18-15-12-9-6-3/h40-42,46H,4-39H2,1-3H3.
What are the key properties of Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate?
Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate has a molecular weight of 708.17 g/mol, XLogP of 12.28, 37 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Heptadecan-9-yl 6-[1-(2-hydroxyethyl)-2-(6-nonoxy-6-oxohexyl)pyrrolidin-3-yl]hexanoate is sourced from PubChem (CID 168821455), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.